Literature DB >> 6966139

Demonstration of a pancreatic proelastase 2-alpha 1-protease inhibitor complex in normal human plasma.

C Largman, J W Brodrick, M C Geokas, J H Johnson, M Fassett.   

Abstract

A peak of immunoreactive pancreatic elastase 2 with a molecular weight consistent with that of a complex of elastase 2 and alpha 1-protease inhibitor (also referred to as alpha 1-antitrypsin) can be detected by radioimmunoassay in normal human serum or plasma (Geokas et al., J. Biol. Chem. 252:61-67, 1977). This material has been purified by gel filtration on Sephadex G-200 and by ion-exchange chromatography on DEAE-cellulose. The alpha 1-protease inhibitor-bound immunoreactive elastase 2 has been dissociated by incubation with hydroxylamine, and the resulting immunoreactive product isolated by gel filtration on Sephadex G-100. The dissociated immunoreactive elastase 2 was shown by affinity chromatography on turkey egg white inhibitor-bound agarose, before and after activation by bovine trypsin, to consist only of proelastase 2. A second peak of immunoreactive material associated with the high molecular weight fraction of plasma has been shown to result from a specific interaction of the 125I-labeled phenylmethanesulfonyl-elastase 2 employed as tracer in the radioimmunoassay with alpha 2-macroglobulin, resulting in apparent immunoreactivity. These results demonstrate that all of the detectable immunoreactive pancreatic elastase 2 in normal human plasma is proelastase 2 bound to alpha 1-protease inhibitor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966139     DOI: 10.1152/ajpgi.1980.238.3.G177

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  What is human pancreatic proelastase 1?

Authors:  C Figarella
Journal:  Int J Pancreatol       Date:  1992-06

2.  Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing.

Authors:  Chrystelle Bonnart; Céline Deraison; Matthieu Lacroix; Yoshikazu Uchida; Céline Besson; Aurélie Robin; Anaïs Briot; Marie Gonthier; Laurence Lamant; Pierre Dubus; Bernard Monsarrat; Alain Hovnanian
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  Elastase-1 vs trypsin, lipase and amylase serum levels in pancreatic diseases.

Authors:  L Benini; P Rizzotti; B Vaona; C Sembenini; G Brocco; R Micciolo; G Chiarioni; P Pederzoli; I Vantini; G Cavallini
Journal:  Int J Pancreatol       Date:  1987 Oct-Dec

4.  Molecular form of pancreatic elastase 1 in human plasma.

Authors:  S Hayakawa; T Hayakawa; T Kondo; T Shibata; S Naruse
Journal:  Int J Pancreatol       Date:  1992-02

5.  Studies on the interactions of human pancreatic elastase 2 with human alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.

Authors:  M Davril; A Laine; A Hayem
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.